EUVIMEDEUVIMED entdecken
Crossref

Enoxaparin attenuates pyrrolizidine alkaloids‐induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression

Hongyu Xiang, Chang Liu, Zhuanglong Xiao, Li Du iD, Ning Wei, Fang Liu, Yuhu Song iD

Liver International · 2023-03 · 43 (3) · 626-638

DOI: 10.1111/liv.15475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 28.11.2022. Verfasst von Hongyu Xiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Hepatic Veno-Occlusive Disease, Pyrrolizidine Alkaloids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The definitive treatment for pyrrolizidine alkaloids (PAs)‐induced hepatic sinusoidal obstruction syndrome (HSOS) is not available. The effectiveness of anticoagulation therapy remains controversial. The efficacy of low molecular weight heparin (LMWH) should be investigated in patients and animal models, and the underlying mechanism should be explored.

Methods

The prognosis of patients with PAs‐HSOS who received anticoagulation therapy was retrospectively analysed. The effect of enoxaparin on the liver injury was determined in animal models of monocrotaline (MCT)‐induced HSOS was determined, and the underlying mechanism was investigated using a murine model.

Results

The cumulative survival rate of patients with PAs‐induced HSOS was 60.00% and 90.90% in the non‐anticoagulation group and anticoagulation group. Enoxaparin attenuated liver injury effectively in a rat model of MCT‐induced HSOS. Additionally, the improvement of severe liver injury was observed in MCT‐treated mice after the administration of enoxaparin (40 mg/kg). The alleviation of liver injury was observed in mice with hepatocyte‐specific deletion of oncostatin M (Osm △Hep ). In MCT‐treated mice administrated with enoxaparin, no significant differences in liver injury were observed between Osm △Hep mice and Osm flox/flox mice. Additionally, adenovirus‐mediated overexpression of Osm resulted in severe liver injury in MCT‐induced mice after the administration of enoxaparin.

Conclusions

LMWH attenuated severe liver injury in patients with PAs‐Induced HSOS and animal models of MCT‐induced HSOS, which provides a rationale for the application of anticoagulation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Veno-Occlusive DiseasePyrrolizidine AlkaloidsRatsMiceAnimalsEnoxaparinRetrospective StudiesHeparin, Low-Molecular-WeightOncostatin MMonocrotalineAnticoagulants

Stichwörter der Autor:innen

hepatic veno-occlusive diseaseinterleukin 6liver injurylow molecular weight heparinoncostatin M

Substanzen

Pyrrolizidine AlkaloidsEnoxaparinHeparin, Low-Molecular-WeightOncostatin MMonocrotalineAnticoagulants

Autor:innen und Institutionen

  • Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Li Du, Yuhu Song

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiang, H., Liu, C., Xiao, Z., Du, L., Wei, N., Liu, F., & Song, Y. (2023). Enoxaparin attenuates pyrrolizidine alkaloids‐induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression. Liver International, 43(3), 626-638. https://doi.org/10.1111/liv.15475

Vancouver

Xiang H, Liu C, Xiao Z, Du L, Wei N, Liu F, et al. Enoxaparin attenuates pyrrolizidine alkaloids‐induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression. Liver International. 2023;43(3):626-638. doi:10.1111/liv.15475

BibTeX
@article{Xiang2023,
  author = {Xiang, Hongyu and Liu, Chang and Xiao, Zhuanglong and Du, Li and Wei, Ning and Liu, Fang and Song, Yuhu},
  title = {Enoxaparin attenuates pyrrolizidine alkaloids‐induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression},
  journal = {Liver International},
  year = {2023},
  volume = {43},
  number = {3},
  pages = {626--638},
  doi = {10.1111/liv.15475}
}
Kostenlos starten →